MedPath
HSA Approval

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

SIN17135P

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial

November 11, 2024

ACX HEALTH PTE. LTD.

Regulatory Information

ACX HEALTH PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

P01BE03

Manufacturer Information

ACX HEALTH PTE. LTD.

Dalton Chemical Laboratories Inc. O/A Dalton Pharma Services

Active Ingredients

Artesunate

110mg/vial

Artesunate

Documents

Package Inserts

Artesunate Amivas Powder and Solvent for Injection 110mg PI.pdf

Approved: November 11, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Artesunate Amivas Powder and Solvent for Solution for Injection 110mg/vial - HSA Approval | MedPath